The burden of chronic obstructive pulmonary disease (COPD) has grown over the last several decades, particularly in specific populations such as women and individuals living in rural areas. COPD is not simply a “smoker’s cough” but an underdiagnosed, life-threatening lung disease. A multitude of factors must be considered when selecting the most appropriate inhaled medication for each patient with COPD. These factors include the patient’s ability to use the device properly, the need for multiple inhaled medications, convenience, patient preferences, clinical evidence, symptom burden, and exacerbation risk. In light of the numerous options available for maintenance therapy for patients with COPD, choosing the most appropriate treatment can be challenging. Moreover, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) consistently updates management recommendations to reflect the latest advances and inform treatment selection. Despite these advances, the management of COPD remains inadequate. The Respiratory Education Hub has been developed to assist health care providers in the diagnosis and management of COPD with CME/CE certified activities from renowned experts in the field, animations that can be used as a teaching tool for team members and patients, and downloadable resources to use in practice.

Teaming Up to Manage Patients with COPD: A Game Plan to Streamline Care

The burden of chronic obstructive pulmonary disease (COPD) has grown substantially in the last several decades, and while the management paradigm for COPD continues to evolve, the treatment of COPD remains inadequate. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) consistently updates management guidelines to reflect the latest advances and inform treatment selection; however, adherence to guidelines is suboptimal. This often leads to comorbidities being underappreciated, inappropriate treatment selection, and poor communication among members of the care team.

This CME Outfitters webcast features both pulmonology and primary care physicians and utilizes an interactive, animated 3-D model of the lung to help bridge the knowledge gap regarding evolving COPD guidelines and optimal treatment.

Participate Now!

Participate in this activity via video or tune into the podcast>>

CMEOCast: Teaming Up to Manage Patients with COPD: A Game Plan to Streamline Care

Tune into the podcast version of this CME Outfitters webcast featuring both pulmonology and primary care physicians in a discussion around evolving COPD guidelines and optimal treatment.Learn best strategies for managing patients with COPD, including:
–    Applying evidence-based treatment guidelines to treatment decisions.
–    Selecting inhaled maintenance treatments for patients based on various factors.
–    Employing multidisciplinary approaches to optimize the continuity of care between primary care practice and pulmonology clinics.

Access the podcast>>

 

Top Takeaways from this Activity: SMART Goals

An Animated Look at COPD Treatments

Take a tour of the different treatments for COPD and their impact on alveoli and at the cellular level. Represented in the animations are short-acting bronchodilators, maintenance treatment with LAMA/LABA, LABA/ICS, LAMA/LABA/ICS.

 

 

An Animated Look at COPD

In this animation, you can take an animated tour of the lungs. Click on different parts of the anatomy to better understand the animation, click to zoom in, turn, or zoom out on the structure. In Chapter 1, we begin with healthy lung that you can move around to better understand. Chapter 2 illustrates COPD with hyperinflation. Moving to Chapter 3, we see healthy alveoli, before comparing alveoli in COPD with exacerbation in Chapter 4. Finally, in Chapter 5 you can see the increase in eosinophils.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2019 Report. Read it here

 

Martinez FJ, Abrahams RA, Ferguson GT, et al. Effects of baseline symptom burden on treatment response in COPD. In J Chron Obstruct Pulmon Dis. 2019;14:181-194. Read it here

 

Hoesterey D, Das N, Janssens W, Buhr RG, Martinez FJ, et al. Spirometric indices of early airflow impairment in individuals at risk of developing COPD: spirometry beyond FEV1/FEC. Respir Med. 2019;156;58-68. Read it here

 

Savran O, Godtfredsen N, Sorensen T. et al. COPD patients prescribed inhaled corticosteroid in general practice: based on disease characteristics according to guidelines? Chron Respir Dis. 2019;16:1479973119867949. Read it here